comparison of glp-1 agonists for weight loss When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations glp-1 agonists vs bariatric surgery

Aberrations in folate metabolic pathway and altered susceptibility to autism

Protocol 2: anxiety and pain presentation (intermediate) Goal: Address both pain and significant anxiety component Peptides: BPC-157 : 500mcg twice daily Selank : 300mcg daily intranasal or subcutaneous Duration: 8-12 weeks Why this works: BPC-157 addresses inflammatory and tissue components

doi: 10.1016/j.biocel.2019.105665

[Article] [PubMed]64

Alcohol works against recovery in a few specific ways

CIH-induced neurocognitive impairments are associated with hippocampal Ca(2+) overload, apoptosis, and dephosphorylation of ERK1/2 and CREB that are mediated by overactivation of NMDARs